J&J’s Single Shot Is EU’s Fourth COVID-19 Vaccine – But Supplies Lag

55 Million Doses Due To Be Supplied In Q2

 
• By Andrew McConaghie
  
Janssen Leiden Netherlands
Development of the vaccine was led by the company's Janssen division in Leiden, Netherlands.
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Vaccines

More from Pink Sheet